Ohara Pharmaceutical

MyDawa is an online pharmacy that provides a convenient platform for individuals to purchase a wide range of high-quality medications and wellness products directly from their mobile devices. By connecting patients to drug stores, MyDawa facilitates affordable access to essential medications without imposing service fees, transaction charges, or delivery costs. This approach aims to streamline the pharmaceutical supply chain, addressing common challenges faced by consumers when sourcing health-related products. MyDawa’s innovative service offers a straightforward and efficient solution for obtaining necessary health items, thereby enhancing the overall customer experience in the healthcare sector.

Africa Healthcare Network (AHN) is a pioneering provider of dialysis services in Sub-Saharan Africa, establishing the first chain of dialysis centers in the region. The organization focuses on delivering high-quality, life-saving dialysis treatment at affordable prices, addressing the critical shortage of accessible care for patients suffering from Acute Kidney Injury (AKI) and End-Stage Renal Disease (ESRD). With a commitment to improving healthcare in a region faced with limited resources and a rising prevalence of Chronic Kidney Disease (CKD) due to urbanization and lifestyle diseases, AHN combines global technical expertise with practical operational experience. The organization aims to enhance the quality of care while reducing costs for patients by securing high-quality equipment, training healthcare professionals, and optimizing operational efficiency. Operating in Rwanda, Tanzania, and Kenya, AHN seeks to increase patient access to essential dialysis services, fostering better health outcomes and providing a sustainable business model.

Africa Healthcare Network (AHN) is a pioneering provider of dialysis services in Sub-Saharan Africa, establishing the first chain of dialysis centers in the region. The organization focuses on delivering high-quality, life-saving dialysis treatment at affordable prices, addressing the critical shortage of accessible care for patients suffering from Acute Kidney Injury (AKI) and End-Stage Renal Disease (ESRD). With a commitment to improving healthcare in a region faced with limited resources and a rising prevalence of Chronic Kidney Disease (CKD) due to urbanization and lifestyle diseases, AHN combines global technical expertise with practical operational experience. The organization aims to enhance the quality of care while reducing costs for patients by securing high-quality equipment, training healthcare professionals, and optimizing operational efficiency. Operating in Rwanda, Tanzania, and Kenya, AHN seeks to increase patient access to essential dialysis services, fostering better health outcomes and providing a sustainable business model.

Helium Health is a technology company focused on transforming healthcare in Africa by providing a comprehensive suite of software solutions for hospitals and clinics. The company specializes in electronic health record systems that facilitate the management of patient data and hospital operations. Its platform simplifies various processes, including doctor visits, prescriptions, and medical billing, making it accessible from any device. Additionally, Helium Health offers customizable forms and tools for monitoring healthcare trends, generating alerts, and producing reports. By leveraging technology, the company aims to create a modern and affordable healthcare system while aspiring to become the largest healthcare data exchange in Africa.

Revital Healthcare is a manufacturer based in Kilifi, Kenya, specializing in medical devices and disposables for hospitals and medical laboratories. Established in 2006, the company produces a range of products, including single-use syringes, needles, re-use prevention syringes, and auto-disable syringes, all designed to minimize the transmission of HIV and other blood-borne diseases. In addition to these syringes, Revital Healthcare offers infusion sets, blood transfusion sets, and blood collection tubes, ensuring that healthcare providers have access to quality and affordable medical supplies.

Hacarus Inc. is a technology company based in Kyoto, Japan, that specializes in artificial intelligence solutions for the manufacturing and medical sectors. Established in 2014, Hacarus develops products that leverage its proprietary Sparse Modeling technology, which allows for efficient data analysis and decision-making. The company offers several key platforms, including SALUS, which caters to medical and life sciences applications, and COLIGO, a customizable application that supports various implementations in IoT and edge computing. Additionally, Hacarus provides SPECTRO, a tool for enhanced visual inspections, and offers data science consulting services along with an AI Academy for education in AI technologies. By focusing on small data and resource-efficient solutions, Hacarus aims to deliver insights that enable faster and more reliable decision-making compared to traditional deep learning approaches.

J-Pharma is a pharmaceutical company dedicated to improving human health by developing novel drugs based on a human-genomic approach. The company focuses on creating selective agents to treat specific diseases, with an emphasis on cell membrane transporters closely associated with various illnesses. J-Pharma's intellectual property includes the discovery of important drug transporters within the human body, which can be used to evaluate and optimize the pharmacokinetics of new drug candidates. Their pipeline aims to produce new therapeutic agents and diagnostic methods, particularly targeting cancer treatment through drugs like anti-cancer agents and PET diagnostic agents against LAT1. The company's ultimate goal is to enhance the quality of life for an aging population in industrialized countries and contribute globally to human welfare.

Helium Health is a technology company focused on transforming healthcare in Africa by providing a comprehensive suite of software solutions for hospitals and clinics. The company specializes in electronic health record systems that facilitate the management of patient data and hospital operations. Its platform simplifies various processes, including doctor visits, prescriptions, and medical billing, making it accessible from any device. Additionally, Helium Health offers customizable forms and tools for monitoring healthcare trends, generating alerts, and producing reports. By leveraging technology, the company aims to create a modern and affordable healthcare system while aspiring to become the largest healthcare data exchange in Africa.

Prism BioLab is focused on drug discovery and development, utilizing its proprietary PepMetics Technology to create therapeutic agents. The company specializes in treatments for non-oncology indications, particularly targeting conditions such as pulmonary fibrosis and other incurable diseases. By leveraging its innovative platform, Prism BioLab aims to provide effective solutions for these challenging health issues.

HekaBio is a healthcare development and commercialization platform focused on advancing innovations in oncology, radiation, and cardiovascular therapies. The company specializes in offering a wide range of development expertise, including pharmaceuticals, medical devices, in-vitro diagnostics, digital health, and cell and gene therapies. By investing in global healthcare technologies, HekaBio aims to facilitate the advancement of breakthrough programs, ultimately enabling researchers to enhance their portfolios. The platform is committed to accelerating patient access to cutting-edge healthcare innovations, thereby improving outcomes in critical areas of health.

Hacarus Inc. is a technology company based in Kyoto, Japan, that specializes in artificial intelligence solutions for the manufacturing and medical sectors. Established in 2014, Hacarus develops products that leverage its proprietary Sparse Modeling technology, which allows for efficient data analysis and decision-making. The company offers several key platforms, including SALUS, which caters to medical and life sciences applications, and COLIGO, a customizable application that supports various implementations in IoT and edge computing. Additionally, Hacarus provides SPECTRO, a tool for enhanced visual inspections, and offers data science consulting services along with an AI Academy for education in AI technologies. By focusing on small data and resource-efficient solutions, Hacarus aims to deliver insights that enable faster and more reliable decision-making compared to traditional deep learning approaches.

Jiksak Bioengineering, Inc. is a biotechnology company specializing in the development of microfluidic devices and screening technologies aimed at addressing neurodegenerative diseases, such as amyotrophic lateral sclerosis and Parkinson's disease. Founded in 2017 and headquartered in Kawasaki, Japan, the company utilizes innovative three-dimensional cell tissue models known as "Nerve Organoids" to enhance drug screening processes. By creating nerve tissue products that mimic human physiology, Jiksak Bioengineering aims to facilitate the identification of effective treatments for these debilitating conditions, ultimately enabling healthcare professionals to improve patient outcomes in the field of neurodegeneration.